Literature DB >> 17956789

Drug treatments for tinnitus.

Cynthia L Darlington1, Paul F Smith.   

Abstract

Many of the drug treatments that are presently in use for tinnitus are aimed at either the cochlea, e.g. using intratympanic injections of gentamicin, dexamethasone or lidocaine, or the CNS using systemic delivery. Earlier benzodiazepines and anticonvulsants have been used and more recently, antidepressants have been introduced, partly in an attempt to treat the emotional aspect of tinnitus. The fact that there are many different forms of tinnitus with different and often multiple causes and that the pathophysiology is poorly understood, are obstacles to finding effective treatments. This situation has been exacerbated by the lack of clinical trials to formally test even some of the most commonly used drugs, as well as a lack of preclinical studies to investigate novel agents. It is suggested that the animal models of tinnitus that have been developed could be used to screen potential anti-tinnitus drugs as a preliminary step before conducting clinical trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956789     DOI: 10.1016/S0079-6123(07)66023-3

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  10 in total

1.  Transcutaneous electrical nerve stimulation (TENS) of upper cervical nerve (C2) for the treatment of somatic tinnitus.

Authors:  Sven Vanneste; Mark Plazier; Paul Van de Heyning; Dirk De Ridder
Journal:  Exp Brain Res       Date:  2010-05-28       Impact factor: 1.972

2.  An active loudness model suggesting tinnitus as increased central noise and hyperacusis as increased nonlinear gain.

Authors:  Fan-Gang Zeng
Journal:  Hear Res       Date:  2012-05-26       Impact factor: 3.208

3.  [Decompensated chronic tinnitus and high-dose benzodiazepine dependence. Between Scylla and Charybdis].

Authors:  U Bonnet
Journal:  Nervenarzt       Date:  2014-07       Impact factor: 1.214

4.  Round window membrane intracochlear drug delivery enhanced by induced advection.

Authors:  David A Borkholder; Xiaoxia Zhu; Robert D Frisina
Journal:  J Control Release       Date:  2013-12-01       Impact factor: 9.776

5.  Localized cell and drug delivery for auditory prostheses.

Authors:  Jeffrey L Hendricks; Jennifer A Chikar; Mark A Crumling; Yehoash Raphael; David C Martin
Journal:  Hear Res       Date:  2008-06-07       Impact factor: 3.208

6.  Evidence that Memantine Reduces Chronic Tinnitus Caused by Acoustic Trauma in Rats.

Authors:  Yiwen Zheng; Emily McNamara; Lucy Stiles; Cynthia L Darlington; Paul F Smith
Journal:  Front Neurol       Date:  2012-08-15       Impact factor: 4.003

7.  Revisiting baclofen for the treatment of severe chronic tinnitus.

Authors:  Paul F Smith; Yiwen Zheng; Cynthia L Darlington
Journal:  Front Neurol       Date:  2012-03-09       Impact factor: 4.003

8.  Cannabinoid CB1 Receptor Agonists Do Not Decrease, but may Increase Acoustic Trauma-Induced Tinnitus in Rats.

Authors:  Yiwen Zheng; Peter Reid; Paul F Smith
Journal:  Front Neurol       Date:  2015-03-18       Impact factor: 4.003

9.  Efficacy of Trimetazidine Dihydrochloride for Relieving Chronic Tinnitus: A Randomized Double-Blind Study.

Authors:  Tolgar Lütfi Kumral; Güven Yıldırım; Güler Berkiten; Ziya Saltürk; Enes Ataç; Yavuz Atar; Yavuz Uyar
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-05-27       Impact factor: 3.372

10.  Protective Effects of Deferoxamine on Vestibulotoxicity in Gentamicin-Induced Bilateral Vestibulopathy Rat Model.

Authors:  Hyo-Jung Kim; Jin-Ok Lee; Ji-Soo Kim
Journal:  Front Neurol       Date:  2021-03-24       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.